FLUCLOX 500 CAP 500MG DIN 00486809
Health Canada record
| Active ingredient(s) | FLOXACILLIN (FLOXACILLIN SODIUM) 500 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01CF05 FLUCLOXACILLIN |
| Original market date | 31-Dec-1981 |
| Current status date | 15-Aug-1997 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLOXACILLIN (FLOXACILLIN SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00525561 | FLUCLOX 250 | AYERST LABORATORIES | Liquid | FLOXACILLIN (FLOXACILLIN SODIUM) 250 MG | Cancelled Post Market |
| 00486795 | FLUCLOX 250 CAP 250MG | AYERST LABORATORIES | Capsule | FLOXACILLIN (FLOXACILLIN SODIUM) 250 MG | Cancelled Post Market |
| 02042134 | FLUCLOX-125 PWS 125MG/5ML | WYETH-AYERST CANADA INC. | Powder For Solution | FLOXACILLIN (FLOXACILLIN SODIUM) 125 MG | Cancelled Post Market |
| 02042118 | FLUCLOX-250 CAP 250MG | WYETH-AYERST CANADA INC. | Capsule | FLOXACILLIN (FLOXACILLIN SODIUM) 250 MG | Cancelled Post Market |